The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases
DOI: https://doi.org/10.2147/tcrm.s462996
2024-05-17
Therapeutics and Clinical Risk Management
Abstract:Giorgio Costagliola, 1 Emanuela De Marco, 1 Francesco Massei, 1 Giulia Roberti, 2 Fabrizio Catena, 1 Gabriella Casazza, 1 Rita Consolini 3 1 Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy; 2 Pediatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy; 3 Section of Clinical and Laboratory Immunology, Pediatric Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 56126, Italy Correspondence: Giorgio Costagliola, Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy, Tel +39-050992841, Email ; Lymphoproliferation is defined by lymphadenopathy, splenomegaly, hepatomegaly, or lymphocytic organ and tissue infiltration. The most common etiologies of lymphoproliferation are represented by infectious diseases and lymphoid malignancies. However, it is increasingly recognized that lymphoproliferative features can be the presenting sign of rare conditions, including inborn errors of immunity (IEI) and inborn errors of metabolism (IEM). Among IEI, lymphoproliferation is frequently observed in autoimmune lymphoproliferative syndrome (ALPS) and related disorders, common variable immunodeficiency (CVID), activated phosphoinositide 3-kinase δ syndrome, and Epstein-Barr virus (EBV)-related disorders. Gaucher disease and Niemann-Pick disease are the most common IEMs that can present with isolated lymphoproliferative features. Notably, other rare conditions, such as sarcoidosis, Castleman disease, systemic autoimmune diseases, and autoinflammatory disorders, should be considered in the differential diagnosis of patients with persistent lymphoproliferation when infectious and malignant diseases have been reasonably ruled out. The clinical features of lymphoproliferative diseases, as well as the associated clinical findings and data deriving from imaging and first-level laboratory investigations, could significantly help in providing the correct diagnostic suspicion for the underlying etiology. This paper reviews the most relevant diseases associated with lymphoproliferation, including infectious diseases, hematological malignancies, IEI, and IEM. Moreover, some practical indications to orient the initial diagnostic process are provided, and two diagnostic algorithms are proposed for the first-level assessment and the approach to persistent lymphoproliferation, respectively. Keywords: lymphadenopathy, splenomegaly, Hodgkin lymphoma, common variable immunodeficiency, autoimmune lymphoproliferative syndrome, gaucher disease Lymphoproliferation is a pathologic condition defined by the presence of lymphadenopathy, splenomegaly, hepatomegaly, or lymphocytic organ and tissue infiltration. These manifestations represent common features observed in patients with infectious diseases, that can be clinically expressed with diffuse lymphoproliferation (especially in case of viral infections) or localized involvement, as observed in patients with lymphadenitis. 1 Lymphoproliferative features are also a hallmark of hematological malignancies, including those with prominent lymph nodal localizations (lymphomas) and those with primary bone marrow involvement and secondary lymph nodal spreading (leukemias). Apart from the infectious and malignant etiologies, the role of lymphoproliferative features as presenting signs of inborn errors of immunity (IEI) and inborn errors of metabolism (IEM) is being increasingly investigated. 2–4 Moreover, systemic autoimmune diseases, autoinflammatory disorders, and rare conditions such as sarcoidosis and Castleman diseases can also present with isolated lymphoproliferation. There are also some significant overlaps in the lymphoproliferative manifestations of IEI, infectious diseases, and hematological malignancies, that further complicate the etiologic and diagnostic scenario. Indeed, while transient lymphoproliferation usually occurs in childhood without consequences, long-standing or recurrent lymphoproliferation is associated with an increased risk of malignant transformation. This is particularly notable in the case of patients suffering from IEI who have an increased susceptibility to Epstein-Barr virus (EBV) infection and a consequent high risk of development of clonal, malignant lymphoproliferation. 2,3 Therefore, the clinical approach to patients presenting with lymphoproliferative features is of great complexity, and the diagnosis of some conditions is often delayed in clinical practice. In this paper, the most relevant clinical characteristics of lymphoproliferation in the context of infectious diseases, hematological malignancies, IEI, and IEM are reviewed. Furthermore, some prac -Abstract Truncated-
health care sciences & services